In DM patients, IL-6R, cystatin B (CSTB), and WAP four-disulfide core domain 2 (WFDC2; or HE4) correlated with global disease activity, but not with muscle or skin disease activity. This evidence concerns the gene WFDC2 and dermatomyositis.